Generic substitution for psychotropic drugs
- PMID: 20085109
- DOI: 10.1017/s1092852900024706
Generic substitution for psychotropic drugs
Erratum in
- CNS Spectr. 2009 Dec;14(12):667
-
Clarification regarding generic substitution for psychotropic drugs.CNS Spectr. 2009 Dec;14(12):709-10. doi: 10.1017/s1092852900023968. CNS Spectr. 2009. PMID: 20394178 No abstract available.
Comment in
-
Clarification regarding generic substitution for psychotropic drugs.CNS Spectr. 2009 Dec;14(12):709-10. doi: 10.1017/s1092852900023968. CNS Spectr. 2009. PMID: 20394178 No abstract available.
Similar articles
-
Clarification regarding generic substitution for psychotropic drugs.CNS Spectr. 2009 Dec;14(12):709-10. doi: 10.1017/s1092852900023968. CNS Spectr. 2009. PMID: 20394178 No abstract available.
-
[Generics in psychiatry--do they have the same therapeutic equivalence as the original?].Neuropsychiatr. 2008;22(4):221-2. Neuropsychiatr. 2008. PMID: 19080992 German. No abstract available.
-
Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective.South Med J. 2011 Oct;104(10):715-6. doi: 10.1097/SMJ.0b013e31822cf201. South Med J. 2011. PMID: 21941163 No abstract available.
-
Rational use of generic psychotropic drugs.CNS Drugs. 2013 May;27(5):353-65. doi: 10.1007/s40263-013-0045-2. CNS Drugs. 2013. PMID: 23620145 Review.
-
United States Food and Drug Administration requirements for approval of generic drug products.J Clin Psychiatry. 2001;62 Suppl 5:4-9; discussion 23-4. J Clin Psychiatry. 2001. PMID: 11305846 Review.
Cited by
-
Potential Clinical and Economic Impact of Switching Branded Medications to Generics.Am J Ther. 2017 May;24(3):e278-e289. doi: 10.1097/MJT.0000000000000282. Am J Ther. 2017. PMID: 26099048 Free PMC article. Review.